Alivus Life Sciences per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY23Mar 2023FY22Mar 2022
₹54.54₹38.11₹35.63
₹54.43₹38.11₹35.63
—₹174.51₹174.81
—₹176.38₹180.67
—₹25.58₹50.85
—₹11.69₹39.60
—₹31.50₹10.95
—12.311.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ALIVUS₹1,397.40

Alivus Life Sciences Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABAARTIDRUGSAKUMSAGARWALEYEAPLLTDADVENZYMESAARTIPHARMCORONA
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Current/LTM
TTM · last close
Basic EPS35.6338.11—54.54
Diluted EPS35.6338.11—54.43
Book Value per Share174.81174.51——
Revenue per Share180.67176.38——
Cash Flow per Share50.8525.58——
Free Cash Flow per Share39.6011.69——
Dividends per Share10.9531.50——
Shares Outstanding (cr)11.812.3——
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.